iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study. Sugimoto N, Kanda J, Nakamura S, Kitano T, et al. Blood 2022;140:2398-2402.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sugimoto N, Kanda J, Nakamura S, Kitano T, et al. iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study. Blood 2022;140:2398-2402.
PMID: 36112961